Search results for: toxic shock syndrome

Filter by:

Date range:
From
To
Categories:
Tags:
Authors:

Showing 1 - 8 of 8 results

5 September 2019

Potential vaccine treats and prevents deadly streptococcal toxic shock

A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock...

Health + Wellbeing Institute for Biomedicine and Glycomics Institute for Glycomics Research
Read More
25 October 2023

World-first human challenge trial to test efficacy of Strep A and rheumatic heart disease vaccine

Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.

Health + Wellbeing Institute for Glycomics Research
Read More
24 October 2023
Blood collection tubes Group A Streptococcus(strep A)

What is Strep A, and why do we need a vaccine?

Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.

Health + Wellbeing Institute for Glycomics
Read More
5 October 2023

Vaccine via the nasal passage could be the new line of defence against Strep A

As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.

Health + Wellbeing Institute for Biomedicine and Glycomics Institute for Glycomics Students
Read More
24 August 2023

Griffith on the cusp of a new vaccine modality breakthrough

Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.

Health + Wellbeing Science + Technology Griffith Institute for Drug Discovery Griffith Sciences Institute for Biomedicine and Glycomics
Read More
10 November 2022

Researchers find Strep A’s Achilles heel with potential vaccine to prevent rheumatic heart disease

A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.

Health + Wellbeing Institute for Biomedicine and Glycomics Institute for Glycomics Research Students
Read More
5 May 2020

New discovery amplifies the impact of novel vaccine

Philanthropy has helped accelerate research into streptococcus leading scientists to exciting new discoveries in stroke and toxic shock prevention and treatments.

Corporate Giving Griffith Enterprise Institute for Biomedicine and Glycomics Research
Read More
12 September 2021

Lights, Camera, Activism with Rachel Griffiths AM

In this conversation Kerry O'Brien speaks to one of Australia's most prolific arts professionals Rachel Griffiths AM about her celebrated career.

Events
Read More